Fong, Tse-Ling <br/><br/>
Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir.  [electronic resource] 

 -  Digestive diseases and sciences  Nov 2015 
 - 3465-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-2568 
<br/><br/><label>Standard No.: </label>10.1007/s10620-015-3775-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antiviral Agents--therapeutic use<br/>Biomarkers--blood<br/>DNA, Viral--blood<br/>Female<br/>Guanine--analogs & derivatives<br/>Hepatitis B e Antigens--blood<br/>Hepatitis B virus--drug effects<br/>Hepatitis B, Chronic--blood<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Remission Induction<br/>Retrospective Studies<br/>Risk Factors<br/>Tenofovir--therapeutic use<br/>Time Factors<br/>Treatment Outcome<br/>Viral Load<br/>Young Adult